Skip to content
Recall Observatory FDA recall evidence

Device product

AFX Endovascular AAA System, Endoleak Type IIIA Product Usage: The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (AAA).

Z-1047-2017

December 27, 2016

Class II

Product summary

Firm
Endologix
Event
Event 76112
Status
Terminated
Classification
Class II
Quantity
Unavailable
Official record key
device-enforcement:Z-1047-2017

Official wording

Reason: Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System (AFX System).

Code information: The correction is not lot specific. It applies to AFX procedures conducted after October 2015

Distribution pattern: US and worldwide: Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Israel, Italy, Latvia, Luxembourg, Monaco, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland, Turkey, United Kingdom.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System (AFX System).

Field note

Send feedback

We'll only use this to respond to your feedback.